Barnidipine
As of the edition of 20 October 2026, Barnidipine is a small molecule: marketed, first approved in 2003 (ES); acts on CACNA1C, CACNA1D and CACNA1F and 1 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2003
- Kind
- Small molecule
- Brand name
- Barnix
- First approved
- 20 March 2003 (ES)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Laboratorios Bial S.A.
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.